Germany: SHS Capital aims to build leading medical technology group with acquisition of majority stake in Ackermann

Germany-based healthcare investor SHS Capital has acquired a majority stake in Ackermann Instrumente, a Germany-basedmanufacturer of high-quality surgical instruments focused on endoscopy, implantology and general surgery.

The investment aims to expand Ackermann’s core business and to establish a leading global medical technology group through targeted partnerships with other companies from the region.SHS sees great potential in Ackermann’s scalable business model and in the company’s international growth strategy.

“Ackermann is a hidden champion of German medical technology – exactly the kind of companies we partner with,” said Dr Cornelius Maas, partner at SHS Capital. “The team has built a highly profitable, internationally active company that offers a compelling value proposition to users and industry partners alike. We look forward to shaping the next chapter of growth –  both organically and through targeted partnerships and acquisitions.”

Ackermann’s vertically integrated in-house production ensures high product quality, cost efficiency and full control along the value chain. Thanks to its strong regulatory expertise and operational flexibility, it has established itself as a reliable partner for healthcare professionals and MedTech companies.

Continuous sales growth as well as a diversified and growing customer base make the company an attractive partner to benefit from the global trend towards minimally invasive surgical procedures – especially in the emerging markets.

Consolidation in the European MedTech market is significantly shaped by MDR requirements and company successions.

“With SHS, we have the opportunity to position Ackermann as a platform for building a powerful medical technology group,” said managing director Peter Grassl. “The combination of regulatory pressure from the MDR, internationalization potential and possible economies of scale makes this step strategically sensible for many companies.”

“SHS is the right partner for corporate succession in medical technology,” says Rolf Ackermann, former majority shareholder of Ackermann Instrumente.

In 2024, Ackermann acquired Allgaier Instrumente, a Frittlingen-based manufacturer of specialty instrumentation.

Press release: Healthcare specialist SHS Capital acquires majority stake in Ackermann Instrumente GmbH with the aim of building a leading medical technology group – SHS Gesellschaft für Beteiligungsmanagement mbH